类风湿关节炎缓解与低疾病活动度达成中的性别差异
该研究利用VARA注册库和2项临床试验数据,评估女性类风湿关节炎患者是否更难达到缓解或低疾病活动度。结果显示,女性DAS28-ESR缓解率更低且持续缓解时间更长,但该差异未见于DAS28-CRP、CDAI或RAPID3,MRI活动度无差异,提示差异主要源于ESR的性别特异性。
要点
- 女性DAS28-ESR缓解率低于男性(OR 0.71),持续缓解时间更长。
- DAS28-CRP、CDAI和RAPID3未见性别差异,MRI滑膜炎和骨炎无差异。
- 女性除ESR<30 mm/h外,其他单项成分更易达标,ESR差异驱动缓解率差异。
核心结论
- 男女缓解率差异取决于疾病活动度测量工具,ESR的性别特异性导致女性缓解率可靠地更低。
- MRI测量的滑膜炎和骨炎无性别差异。
研究设计与样本
- 基于VARA注册库2463例患者和2项临床试验353例参与者(83.7%女性)的回顾性分析。
- VARA注册库用logistic回归评估随访期间任一时点缓解可能性,用Cox比例风险模型评估持续缓解(连续2次访视)时间。
- 临床试验用logistic回归评估52周时低临床和MRI活动度的可能性。
主要发现
- VARA注册库中女性(10.2%)DAS28-ESR缓解可能性更低(OR 0.71 [95%CI 0.55-0.91];P<0.01),持续DAS28-ESR缓解时间更长。
- VARA注册库中DAS28-CRP、CDAI或RAPID3未见性别差异。
- 女性除ESR<30 mm/小时外(OR 0.72 [95%CI 0.57-0.90];P<0.01),其他单项成分更易达标。
- 临床试验中女性DAS28-ESR缓解率更低(OR 0.39 [95%CI 0.21-0.72];P=0.003),但低MRI滑膜炎和骨炎率相似。
关键数值与推荐
- 缓解和低疾病活动度采用复合评分、单项(压痛关节、肿胀关节、ESR、CRP、评估者/患者总体评估)和MRI定义。
临床怎么用
- 临床评估RA疾病活动度时需注意ESR相关复合评分可能低估女性缓解率,可结合CRP、CDAI或RAPID3及影像学综合判断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: In rheumatoid arthritis, whether women are less likely to achieve low disease activity is unclear. We evaluated sex differences in remission and low disease activity, comparing different clinical and imaging measures. METHODS: We used data from the Veterans Affairs Rheumatoid Arthritis (VARA) registry and from 2 clinical trials. Remission and low disease activity were defined using composite scores, individual items (tender joints, swollen joints, erythrocyte sedimentation rate [ESR], C-reactive protein [CRP] level, and evaluator/patient global assessment), and magnetic resonance imaging (MRI). In the VARA registry, we assessed the likelihood of point remission at any time during follow-up using logistic regression, and time to sustained remission (2 consecutive visits) using Cox proportional hazards models. In the clinical trials, logistic regression models evaluated the likelihood of low clinical and MRI activity at 52 weeks. RESULTS: Among 2,463 patients in VARA, women (10.2%) were less likely to be in Disease Activity Score in 28 joints (DAS28)-ESR remission in follow-up (odds ratio [OR] 0.71 [95% confidence interval (95% CI) 0.55-0.91]; P < 0.01) and had a longer time to sustained DAS28-ESR remission. This difference was not observed for DAS28-CRP, Clinical Disease Activity Index, or Routine Assessment of Patient Index Data 3. Women were more likely to achieve favorable individual components except for an ESR <30 mm/hour (OR 0.72 [95% CI 0.57-0.90]; P < 0.01). Among 353 trial participants (83.7% women), women had reduced rates of DAS28-ESR remission (OR 0.39 [95% CI 0.21-0.72]; P = 0.003) but similar rates of low MRI synovitis and osteitis. CONCLUSION: The comparison of remission rates between men and women varies based on the disease activity measure, with sex-specific differences in ESR resulting in reliably lower rates of remission among women. There were no differences in MRI measures.
引用
- Maynard C, Mikuls TR, Cannon GW, et al. Sex Differences in the Achievement of Remission and Low Disease Activity in Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2020. PMID: 30875461. doi:10.1002/acr.23873
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。